EBC-46, a novel PKC inhibitor shows pre-clinical potential

New cancer drug promising, but has a long way to go

A recent article published in Medical Express last week touts the impressive findings of a pre-clinical study on the experimental drug EBC-46 (pictured above). In the article, they claim that EBC-46 is able to effectively destroy tumors by destroying the blood vessels that supply it with oxygen and nutrients. It is important, however, to remember that the work they are reporting on is very preliminary … Continue reading New cancer drug promising, but has a long way to go